Evaluation of oxidative stress in the thrombolysis of pulmonary embolism

Journal of Thrombosis and Thrombolysis

Volumn 22, Issue 3, 2006, Pages 221-228

  Mühl, Diana ^a   Füredi, Réka ^a   Cristofari, Julia ^a   Ghosh, Subhamay ^a   Bogár, Lajos ^a   Borsiczki, Balázs ^a   Gasz, Balázs ^a   Rőth, Elizabeth ^a   Lantos, János ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Leukocyte activation; Oxidative stress; Pulmonary embolism; Thrombolysis

Indexed keywords

ALTEPLASE; CD18 ANTIGEN; CD97 ANTIGEN; GLUTATHIONE; LYMPHOCYTE ANTIGEN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MALONALDEHYDE; MYELOPEROXIDASE; REACTIVE OXYGEN METABOLITE; STREPTOKINASE; SUPEROXIDE DISMUTASE; THIOL GROUP;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MECHANISM; DRUG MEGADOSE; FEMALE; FIBRINOLYSIS; FIBRINOLYTIC THERAPY; FLOW CYTOMETRY; HUMAN; LEUKOCYTE ACTIVATION; LEUKOCYTE FUNCTION; LUNG EMBOLISM; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 33845259832     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-006-9035-2     Document Type: Article

References (32)

1. Goldhaber SZ, Visani L, De Rosa M (1999) Acute pulmonary embolism: clinical outcomes in the International Cooperation Pulmonary Embolism Registery (ICOPER). Lancet 353:1386-1389
2. Janata K, Holzer M, Domanovits H et al (2002) Mortality of patients with pulmonary embolism. Wien Klin Wochenschr 114:766-772
3. Meneveau N, Ming LP, Seronde MF et al (2003) In hospital and long-term outcome after sub-massive and massive pulmonary embolism submitted to thrombolytic therapy. Eur Heart J 24:1447-1454
4. Konstantinides S, Geibel A, Olschewski M et al (1997) Association between thrombolytic treatment and the prognosis of hemodynamically stable patients with major pulmonary embolism. Results of a multicenter registry. Circulation 96:882-888
5. Büchner S, Pfeiffer B, Hachenberg Th (2005) Lungenembolie (CME 1/2/ 2005). Anästh Intensivmed 46:9-22
6. Reilly PM, Schiller HJ, Bulkley GB (1991) Pharmacologic approach to tissue injury mediated by free radicals and other reactive oxygen metabolites. Am J Surg 161:488-503
7. Ryrfeldt A, Bannenberg G, Moldeus P (1993) Free radicals and lung disease. Br Med Bull 49:588-603
8. Dikshit M, Srivastava R, Srimal RC (1989) Role of free radicals in pulmonary thromboembolism in mice. Thromb Res 55:549-557
9. Dikshit M, Kumari R, Srimal RC (1992) Effect of pulmonary thromboembolism on circulating neutrophils in mice. Thromb Res 66:133-139
10. Souza-Costa DC, Zerbini T, Metzger IF, Rocha JB, Gerlach RF, Tanus-Santos JE (2005) l -Arginine attenuates acute pulmonary embolism-induced oxidative stress and pulmonary hypertension. Nitric Oxide 12:9-14
11. Re G, Lanzarini C, Vaona I, Pazzaglia M, Palareti G, Bassein L, Guarnieri C (1998) Systemically circulating oxidative species in human deep venous thrombosis. Eur J Emerg Med 5:9-12
12. Shimizu Y, Nagaya N, Satoh T, Uematsu M, Kyotani S, Sakamaki F, Nakanishi N, Miyatake K (2002) Serum uric acid level increases in proportion to the severity of pulmonary thromboembolism. Circ J 66:571-575
13. Martin M, Eikerling B (1990) Tödliche. Lungenembolie unter Ultra-hoch-dosierter Streptokinase-Behandlung. Dtsch Med Wochenschr 115:1812
14. Sárosi I, Mühl D, Tekeres M et al (1998) What to do in 1998? The urgent lifesaving non-surgical treatment of subtotal pulmonary embolism. World Congress Cardiol XIII:1019-1023
15. Torbicki A, Van Beek EJR, Charbonnier B et al (2000) Guidelines on diagnosis and management of acute pulmonary embolism. Eur Heart J 21:1301-1336
16. Goldhaber SZ, Haire WD, Feldstein ML et al (1993) Alteplase versus heparin in acut pulmonary embolism: Randomised trial assessing right-ventricular function and pulmonary perfusion. Lancet 341:507-511
17. Goldhaber SZ (1997) Pulmonary embolism thrombolysis: Broadening the paradigm for its administration. Circulation 96:716-718
18. Goldhaber SZ, Elliott CG (2003) Acute pulmonary embolism: Part II: Risk stratification, treatment, and prevention. Circulation 108:2834-2838
19. Ohakawa HN, Okishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351-358
20. Sedlak J, Lindsay RH (1968) Estimation of total protein-bound and non-protein sulphydryl groups in tissue with Ellman's reagent. Anal Biochem 25:192-205
21. Misra HP, Fridovich I (1972) The role of superoxide anion in the antioxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 27:3170-3175
22. Le Gal G, Bounameaux H (2004) Diagnosing pulmonary embolism: Running after the decreasing prevalence of cases among suspected patients. J Thromb Haemost 2:1244-1246
23. Smulders YM (2000) Pathophysiology and treatment of haemodynamic instability in acute pulmonary embolism: The pivotal role of pulmonary vasoconstriction. Cardiovasc Res 48:23-33
24. Lualdi JC, Goldhaber SZ (1995) Right ventricular dysfunction after acute pulmonary embolism: Pathophysiologic factors, detection, and therapeutic implications. Am Heart J 130:1276-1282
25. Kurose I, Granger DN (1994) Evidence implicating xanthine oxidase and neutrophils in reperfusion-induced microvascular dysfunction. Ann NY Acad Sci 723:158-179
26. Shimizu Y, Nagaya N, Satoh T et al (2002) Serum uric acid level increases in proportion to the severity of pulmonary thromboembolism. Circ J 66:571-575
27. Utsonomiya T, Krausz MM, Levine L, Shepro D, Hechtman HB (1982) Thromboxane mediation of cardiopulmonary effects of embolism. J Clin Invest 70:361-368
28. Babior BM (1982) The enzymatic basis for O-.2 production by human neutrophils. Can J Phys Pharm 60:1353-1358
29. Wagner JG, Roth RA (2000) Neutrophil migration mechanisms, with an emphasis on the pulmonary vasculature. Pharmacol Rev 52:349-374
30. Albelda SM, Smith CW, Ward PA (1994) Adhesion molecules and inflammatory injury. FASEB J 8:504-512
31. Dreyer WJ, Burns AR, Phillips SC, Lindsey ML, Jackson P, Kukielka GL (1998) Intercellular adhesion molecule-1 regulation in the canine lung after cardiopulmonary bypass. J Thorac Cardiovasc Surg 115:689-698
32. Martin M, Eikerling B (1990) Todie;dliche. Lungenembolie unter Ultra-hoch-dosierter Streptokinase-Behandlung. Dtsch Med Wochenschr 115:1812